CJC-1295 + Ipamorelin 10mg
Growth Hormone Optimization
View Certificate of AnalysisCompound Overview
CJC-1295 + Ipamorelin is a pre-blended combination of two growth hormone secretagogue peptides that act through complementary pathways. CJC-1295 (with DAC) is a modified growth hormone-releasing hormone (GHRH) analog that extends GH pulse duration, while Ipamorelin is a selective ghrelin receptor agonist (growth hormone secretagogue receptor, GHSR) that initiates GH release with minimal effect on cortisol or prolactin.
Each vial contains 10mg of lyophilized CJC-1295 + Ipamorelin blend (5mg + 5mg) at ≥99% purity, independently verified by Testides (Toronto).
Lab results: View current batch COA
Specifications
| Compound | CJC-1295 (with DAC) + Ipamorelin blend |
| Compound class | GHRH analog + selective ghrelin/GHSR agonist (growth hormone secretagogues) |
| Vial contents | 10 mg lyophilized blend (5 mg CJC-1295 + 5 mg Ipamorelin) |
| Verified purity | ≥99% (HPLC) |
| Testing laboratory | Testides, Toronto (ISO 17025-aligned) |
| Test methods | HPLC purity + mass spectrometry identity confirmation |
| Compatible solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Storage | Lyophilized: -20°C long-term, 2-8°C short-term. Protect from light |
| Research applications | Growth hormone pulse research, GHRH receptor signalling, ghrelin/GHSR pathway, body composition and recovery studies |
| Ships from | British Columbia, Canada |
| Intended use | In-vitro laboratory research only |
Research Context & Mechanism+
The CJC-1295 + Ipamorelin combination is studied for its dual-pathway approach to growth hormone research. CJC-1295 extends GH pulse duration by binding to the GHRH receptor, while Ipamorelin activates the ghrelin/GHSR pathway to initiate discrete GH pulses.
Published research on Ipamorelin includes Raun et al. (European Journal of Endocrinology, 1998, PMID: 9893259) establishing its selectivity profile. Teichman et al. (Journal of Clinical Endocrinology & Metabolism, 2006, PMID: 16384846) evaluated CJC-1295's extended half-life and sustained GH elevation.
This combination is commonly studied alongside metabolic peptides like semaglutide and retatrutide in broader endocrine signaling research.
Purity & Third-Party Testing+
Independently tested by Testides (Toronto) — HPLC ≥99% purity and mass spectrometry confirmation. View COA →
Storage & Handling+
Lyophilized: -20°C long-term, 2-8°C short-term.
Shipping & Delivery+
Ships from BC. Tracked Canada-wide. 48-hour processing. Shipping policy →
Returns & Refunds+
Contact info@thepeptide.ca within 48 hours for damaged orders. Refund policy →
For laboratory and research use only. Not for human consumption, veterinary use, or therapeutic application. Not approved by Health Canada.
- Sealed vial: −20°C, 24+ months.
- Protect from light and heat.
- Keep in original packaging until use in the laboratory.
- CJC-1295: 5 mg + Ipamorelin: 5 mg
- Total: 10 mg pre-blended
- Class: GHRH analogue + GH secretagogue
- Purity: ≥99% (HPLC)
Not for human or animal use. We do not publish preparation, dilution or administration guidance of any kind.
By purchasing, you confirm research intent and accept full responsibility for compliance.
Mix any research peptides 10 mg or larger — the discount counts your whole order, not one product.
YOU MAY ALSO LIKE
SHOP ALL
Frequently Bought Together
Laboratory supplies commonly ordered alongside research compounds.
Bacteriostatic Water 10mL — Sterile Multi-Use Laboratory Water with 0.9% Benzyl Alcohol
Essential Reconstitution Supply
STARTING AT ▸ $22.00
Insulin Syringes 10-Pack — 1mL, 29G × ½" Sterile Single-Use Laboratory Syringes
Sterile. Ultra-fine. Individually wra...
Why ThePeptide
Most research peptide sellers ask you to take their word for it. We publish the receipts.
